BackInnate Pharma Overview

Innate Pharma Total Revenue

Revenue analysis for IPHA.

Quarterly Revenue

$1.11M
↑ 301.35% YoY

As of Dec 2025

Annual Revenue (TTM)

$12.42M
↓ 81.95% YoY

Trailing 12 months ending Dec 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin